Document is current
Any future updates will be listed below
-
Authors
Ogiwara, Kenichi
Nogami, Keiji https://orcid.org/0000-0002-2415-2194
Matsumoto, Naoki
Noguchi-Sasaki, Mariko
Hirata, Michinori
Soeda, Tetsuhiro
Shima, Midori
-
Funding
Funding for this research was provided by:
Ministry of Education, Culture, Sports, Science and Technology (18K07885)
- License Information
-
More Information
Article History
Received: 3 April 2020
Revised: 18 June 2020
Accepted: 21 July 2020
First Online: 3 August 2020
Compliance with ethical standards
:
: KO, KN, and MS receive research support from Chugai Pharmaceutical Co., Ltd. (Chugai), and are engaged in clinical studies sponsored by Chugai and F. Hoffmann-La Roche. KN and MS receive (consulting) honoraria from these companies. TS, KN, and MS are inventors of the patents relating to emicizumab. NM, MN-S, MH and TS are employees of Chugai. NM and MH own Chugai stock.
